Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | — | OT |
immediate bad cough; blurred vision; Allergic reaction; Initial information received on 23-Jul-2025 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves an unknown age female patient who had immediate bad cough, blurred vision and allergic reaction after receiving influenza USP TRIVAL A-B subvirion no preservative vaccine [Fluzone]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of influenza USP TRIVAL A-B subvirion no preservative vaccine Suspension for injection (strength, expiry date and lot number not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunization). On an unknown date the patient developed immediate bad cough (cough), blurred vision (vision blurred) and allergic reaction (hypersensitivity) (unknown latency). Reportedly, patient developed an immediate bad cough, and blurred vision after receiving fluzone - which went away after about two weeks. Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. It was not reported if the patient received a corrective treatment for all the events. At time of reporting, the outcome was Recovered / Resolved on an unknown date for all the events.